Form 4: ProAssurance Director Samuel A. Di Piazza Jr. Reports Acquisition of Shares Under Deferred Stock Compensation Plan
SEC Form 4 Filing
Director Samuel A. Di Piazza Jr. reports acquiring 13,988 shares of ProAssurance Corp. common stock through the company's Director Deferred Stock Compensation Plan.
Summary
- On May 23, 2024, Samuel A. Di Piazza Jr., a director of ProAssurance Corp, reported acquiring 13,988 shares of common stock.
- The acquisition was made under the ProAssurance Corporation Director Deferred Stock Compensation Plan.
- The price per share was $14.57.
- Following the transaction, Di Piazza directly owns 40,880 shares of ProAssurance Corp.
- The shares were awarded as part of the director's compensation, with a portion covering services to the Board for the preceding twelve months.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The acquisition of shares by a director is generally viewed as a positive sign, indicating confidence in the company's future prospects. However, it's a routine transaction related to compensation, so the impact is limited.
Positives
- The acquisition of shares by a director signals confidence in the company.
- The stock compensation plan aligns director interests with shareholder value.
Industry Context
Director stock ownership is a common practice in publicly traded companies to align the interests of management with shareholders. This Form 4 filing is a routine disclosure required by the SEC.
Comparison to Industry Standards
- Director compensation packages often include stock options or grants to incentivize performance and align interests with shareholders.
- Companies like UnitedHealth Group (UNH) and Anthem (ANTM), also in the healthcare sector, have similar director compensation plans that include stock awards.
- The value of the stock compensation grant ($95,000) is within the typical range for non-management directors in companies of similar size and industry.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns director interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 2019-05-22 | Date of Power of Attorney execution. |
| 2024-05-22 | Board of Directors approved the stock compensation grant. |
| 2024-05-23 | Date of transaction (acquisition of shares) and NYSE closing price used to determine share distribution. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.